First Trust Nasdaq Pharmaceuticals ETF
FTXH
FTXH
13 hedge funds and large institutions have $10.6M invested in First Trust Nasdaq Pharmaceuticals ETF in 2020 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
13
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.59M | |
| 2 | +$1.21M | |
| 3 | +$111K | |
| 4 |
IAIM
International Assets Investment Management
Orlando,
Florida
|
+$68.9K |
| 5 |
SPIA
Steward Partners Investment Advisory
New York
|
+$10K |
Top Sellers
| 1 | -$748K | |
| 2 | -$349K | |
| 3 | -$213K | |
| 4 |
CAN
Cetera Advisor Networks
El Segundo,
California
|
-$20K |
| 5 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$15K |